| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2011/04/08 | 04:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/08 | 03:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/08 | 03:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/08 | 03:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/08 | 01:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/08 | 01:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 05:53 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 05:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 05:39 | Business Wire | CPEX Completes Sale to FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 04:59 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 04:56 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 03:46 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 03:42 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/04/06 | 02:53 | PR Newswire (US) | Footstar Completes Acquisition of CPEX Pharmaceuticals, Inc. | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/31 | 23:54 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/30 | 23:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/24 | 22:21 | Business Wire | CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/24 | 04:00 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/23 | 20:00 | Business Wire | CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/23 | 19:02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/22 | 21:30 | PR Newswire (US) | Mangrove Partners Notes CPEX Stock Trading Above Offer Price | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/22 | 05:31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/22 | 00:56 | Business Wire | CPEX Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/21 | 21:30 | PR Newswire (US) | Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and In | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/19 | 05:27 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/19 | 05:21 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/18 | 22:36 | Business Wire | CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/18 | 06:13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/18 | 06:09 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |
| 2011/03/17 | 22:34 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:CPEX | Cpex Pharmaceuticals, Inc. (MM) |